ADVERTISEMENT
Posted: Sep 7, 2024

Gabapentinoid-loop diuretic study sheds light on broader cascade risks

Adverse Effects

Prescribing cascades are under-recognized as a contributor to polypharmacy among older adults, according to a recent paper published in the Journal of the American Geriatrics Society on March 28, 2024, that specifically looked at gabapentinoid-loop diuretic cascades.

Elizabeth Briand

Read more
Posted: Sep 7, 2024

ACPE’s Jan Engle discusses new PharmD standards

Education

At a June 2024 meeting, the board of directors for the Accreditation Council for Pharmacy Education (ACPE) approved new accreditation standards for the PharmD degree.

Loren Bonner

Read more
Posted: Sep 7, 2024

New and Approved

Updates from FDA

Updates from FDA

Read more
Posted: Sep 7, 2024

Smoking cessation with e-cigarettes raises concerns

Smoking Cessation

A randomized placebo-controlled single-center Finnish study published in JAMA Internal Medicine on June 17, 2024, showed that varenicline and e-cigarettes had similar rates of smoking cessation at 52 weeks.

Clarissa Chan, PharmD

Read more
Posted: Sep 7, 2024

A new maintenance treatment option for adults living with COPD

New Drug

In June 2024, for the first time in over a decade, FDA approved a new drug to treat adult patients with COPD.

Lauren Howell, PharmD

Read more
12

Related Articles

Advertisement
Advertisement
Advertisement
Advertisement
ADVERTISEMENT